
Chloroquine | CAS:54-05-7
Chloroquine
- 名称:氯喹盐基; 4-(4-二乙氨基-1-甲基丁氨基)-7-氯喹啉 | Chloroquine
- CAS号:54-05-7
- 别名:4-(4-Diethylamino-1-methylbutylamino)-7-chloroquinoline
- 分子式:C18H26ClN3
- 分子量:319.87
- EINESC号:200-191-2
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Functional screenings reveal different requirements for host microRNAs in Salmonella and Shigella infection.Carmen Aguilar et al.Nature microbiology, 5(1), 192-205 (2019-12-04)
MICU1 Confers Protection from MCU-Dependent Manganese Toxicity.Jennifer Wettmarshausen et al.Cell reports, 25(6), 1425-1435 (2018-11-08)
Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis.Aateka Patel et al.Pharmaceutics, 11(7) (2019-07-20)
Evaluation of autophagy inducers in epithelial cells carrying the DeltaF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTRZhang S, et al. Cell Death & Disease, 9(2), 191-191 (2018)
High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.Fabian Alexander Grimm et al.Assay and drug development technologies, 13(9), 529-546 (2015-11-06)
Multiparametric assay using HepaRG cells for predicting drug-induced liver injury.Takafumi Tomida et al.Toxicology letters, 236(1), 16-24 (2015-05-03)
Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditionsYoshida, M.I., et al. Drug Devel. Ind. Pharm., 37, 638-647 (2011)
Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymesTang, L., et al. Toxicology Letters, 2022, 47-54 (2011)
Kaplan's Cardiac Anesthesia E-Book: Expert Consult Premium, 281 (2011)
Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.Miaoying Shi et al.Toxicology in vitro : an international journal published in association with BIBRA, 67, 104891-104891 (2020-05-25)
Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer.Priyatham Gorjala et al.Cancers, 12(4) (2020-04-23)
Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk.Haruka Okamoto et al.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1051, 33-40 (2017-03-13)
Embolization of the first diagonal branch of the left anterior descending coronary artery as a porcine model of chronic trans-mural myocardial infarction.Derek W Hanes et al.Journal of translational medicine, 13, 187-187 (2015-06-07)
In Vitro Multiparameter Assay Development Strategy toward Differentiating Macrophage Responses to Inhaled Medicines.Ewelina Hoffman et al.Molecular pharmaceutics, 12(8), 2675-2687 (2015-05-06)
A live zebrafish-based screening system for human nuclear receptor ligand and cofactor discovery.Jens Tiefenbach et al.PloS one, 5(3), e9797-e9797 (2010-03-27)
Editor?s Highlight: Transgenic Zebrafish Reporter Lines as Alternative In Vivo Organ Toxicity ModelsPoon K, et al. Toxicological Sciences, 156(1), 133-148 (2017)
Antiarrhythmic efficacy of CPUY102122, a multiple ion channel blocker, on rabbits with ischemia/reperfusion injury.Minhui Wang et al.Pharmacological reports : PR, 66(6), 1022-1030 (2014-12-03)
In vitro thyroid disrupting effects of organic extracts from WWTPs in Beijing.Na Li et al.Journal of environmental sciences (China), 23(4), 671-675 (2011-07-29)
Quality evaluation and pattern recognition analyses of bioactive marker compounds from Farfarae Flos using HPLC/PDA.U Min Seo et al.Chemical & pharmaceutical bulletin, 63(7), 546-553 (2015-05-15)
Imaging drugs, metabolites and biomarkers in rodent lung: a DESI MS strategy for the evaluation of drug-induced lipidosis.Alex Dexter et al.Analytical and bioanalytical chemistry, 411(30), 8023-8032 (2019-11-30)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!